<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39346665</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2732-494X</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>1</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Antimicrobial stewardship &amp; healthcare epidemiology : ASHE</Title><ISOAbbreviation>Antimicrob Steward Healthc Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Levees for a hundred-year flood: impact of a syndrome-based antimicrobial stewardship intervention for coronavirus disease 2019 on antimicrobial use and resistance.</ArticleTitle><Pagination><StartPage>e131</StartPage><MedlinePgn>e131</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e131</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1017/ash.2024.383</ELocationID><Abstract><AbstractText>Coronavirus disease 2019 can be indistinguishable from lower respiratory tract infections (LRTIs) caused by other viral and bacterial agents. This likely contributed to antimicrobial use (AU) and antimicrobial resistance (AMR) during the pandemic. Our antimicrobial stewardship program targeted the selection and duration of therapy for LRTIs and led to a reduction in AU and AMR.</AbstractText><CopyrightInformation>© Cambridge University Press 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mena Lora</LastName><ForeName>Alfredo J</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0002-8337-757X</Identifier><AffiliationInfo><Affiliation>University of Illinois at Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Saint Anthony Hospital, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burgos</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Illinois at Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huber</LastName><ForeName>Dylan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Saint Anthony Hospital, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchez</LastName><ForeName>Lawrence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Saint Anthony Hospital, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Mirza</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0001-4598-7123</Identifier><AffiliationInfo><Affiliation>Saint Anthony Hospital, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krill</LastName><ForeName>Candice</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Saint Anthony Hospital, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takhsh</LastName><ForeName>Eden</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Saint Anthony Hospital, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bleasdale</LastName><ForeName>Susan C</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0001-7448-6259</Identifier><AffiliationInfo><Affiliation>University of Illinois at Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Antimicrob Steward Healthc Epidemiol</MedlineTA><NlmUniqueID>9918266096106676</NlmUniqueID><ISSNLinking>2732-494X</ISSNLinking></MedlineJournalInfo><CoiStatement>All authors report no conflicts of interest relevant to this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>16</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>9</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39346665</ArticleId><ArticleId IdType="pmc">PMC11427971</ArticleId><ArticleId IdType="doi">10.1017/ash.2024.383</ArticleId><ArticleId IdType="pii">S2732494X24003838</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727–733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauci AS, Folkers GK. Pandemic preparedness and response: lessons from COVID-19. J Infect Dis 2023;228:422–425.</Citation><ArticleIdList><ArticleId IdType="pubmed">37035891</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaba SM, Jones G, Helsel T, et al. Prevalence of co-infection at the time of hospital admission in COVID-19 patients, a multicenter study. Open Forum Infect Dis 2021;8:ofaa578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7793465</ArticleId><ArticleId IdType="pubmed">33447639</ArticleId></ArticleIdList></Reference><Reference><Citation>Langford BJ, So M, Raybardhan S, et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect 2021;27:520–531.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7785281</ArticleId><ArticleId IdType="pubmed">33418017</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention. COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report 2022. https://stacks.cdc.gov/view/cdc/117915. 2022, doi: 10.15620/cdc:117915.</Citation><ArticleIdList><ArticleId IdType="doi">10.15620/cdc:117915</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyar, O. J. , Huttner, B. , Schouten, J. &amp; Pulcini, C. What is antimicrobial stewardship? Clin Microbiol Infect 2017;23:793–798.</Citation><ArticleIdList><ArticleId IdType="pubmed">28882725</ArticleId></ArticleIdList></Reference><Reference><Citation>Mena Lora, A. J. et al. Divide and conquer: feasibility and impact of antimicrobial stewardship in a safety-net community hospital after a syndrome-based education initiative for pharmacists. J Am Coll Clin Pharm 2021;4:580–586.</Citation></Reference><Reference><Citation>Mena Lora, A. J. , Burgos, R. , Borgetti, S. , Chaisson, L. H. &amp; Bleasdale, S. C. Antimicrobial stewardship and drug formulary restrictions during COVID-19: what is restricted and who decides? Antimicrobial stewardship &amp; healthcare epidemiology: ASHE 2023;3:e116 (.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10369429</ArticleId><ArticleId IdType="pubmed">37502239</ArticleId></ArticleIdList></Reference><Reference><Citation>Mena Lora, A. J. , Burgos, R. , Borgetti, S. , Chaisson, L. H. &amp; Bleasdale, S. C. Remdesivir use and antimicrobial stewardship restrictions during the coronavirus disease 2019 (COVID-19) pandemic in the United States: a cross-sectional survey. Antimicrobial Stewardship &amp; Healthcare Epidemiology 2023;3: e63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10127235</ArticleId><ArticleId IdType="pubmed">37113205</ArticleId></ArticleIdList></Reference><Reference><Citation>Mena Lora, A. J. et al. Impact of a syndrome-based stewardship intervention on antipseudomonal beta-lactam use, antimicrobial resistance, C. difficile rates, and cost in a safety-net community hospital. Antimicrobial stewardship &amp; healthcare epidemiology: ASHE 2024;4:e31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10945933</ArticleId><ArticleId IdType="pubmed">38500719</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>